BioMarin Pharmaceutical
BMRN
#1437
Rank
C$16.70 B
Marketcap
$87.10
Share price
1.29%
Change (1 day)
-30.31%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): $1.05

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.08. In 2022 the company made an earnings per share (EPS) of $1.07 an increase over its 2021 EPS that were of -$0.49.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.05-1.96%
2022$1.07-319.62%
2021-$0.49-107.38%
2020$6.58-3485.71%
2019-$0.19-67.44%
2018-$0.60-34.85%
2017-$0.92-83.21%
2016-$5.46263.89%
2015-$1.5018.68%
2014-$1.26-28.91%
2013-$1.7834.74%
2012-$1.3293.88%
2011-$0.68-124.5%
2010$2.78
2009N/A-100%
2008$0.44-300%
2007-$0.22-54.29%
2006-$0.49-67.89%
2005-$1.51-62.54%
2004-$4.04136.59%
2003-$1.71-15.17%
2002-$2.01-11.59%
2001-$2.2856.19%
2000-$1.4610.53%
1999-$1.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$14.22-1,415.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.00-284.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.92-462.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.42 308.43%๐Ÿ‡ซ๐Ÿ‡ท France
-$0.89-182.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.53 41.27%๐Ÿ‡บ๐Ÿ‡ธ USA